“…Forty seven percent first sought care in a government hospital, 26% with a patent medicine vendor and 22% in a private hospital. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…According to the ultrasonographic findings, the patients were divided into two sub-groups: 187 pts (85 %) with patent RA after PCI and 33 pts (15 %) with RAO. Both sub-groups significantly statistically differed with regard to the frequency of local hematomas—15 versus 27.3 % (p = 0.02), the frequency of applying IIbIIIa inhibitors in PCI—6.4 versus 15.1 % (p = 0.015) and procedure duration—0.59 ± 0.37 versus 0.77 ± 0.38 (p = 0.014), respectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…METHODS: The study comprised 3,580 patients who were treated with curative intent either by laparoscopic gastrectomy (2,041 patients) or open gastrectomy (1,539 patents) between January 2005 and October 2013. The surgical outcomes were compared between the two groups. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Twenty eight (52.8%) were ruptured aneurysms, and 25 (47.2%) were unruptured aneurysms. The patents' medical and radiological records were reviewed retrospectively. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…CONCLUSION: Unilateral placement of ePTFE-covered and uncovered stents in the hepatic lobe with a patent portal vein is a safe and effective method for palliative treatment of patients with a contralateral portal vein steno-occlusion caused by an advanced hilar malignancy or portal vein embolization. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…The C8910 formulation is a patented mixture of compounds comprising straight-chain octanoic, nonanoic and decanoic saturated fatty acids. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: uDelta was performed on 11 patents, and uncut RY was performed on 5-patients without open or multiport conversion. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Additionally, a public education program to increase the awareness of early symptoms and the necessity of visiting the hospital early should be established as the first priority to improve the outcome of AMI patents, especially in county-level local areas.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Intubation-Surfactant administration- Rapid Extubation (INSURE) failure rate as primary outcome and secondary outcome as follow: duration of the need to NCPAP, mechanical ventilation and oxygen therapy; complications (patent ductus arteriosus, pneumothorax); mortality (respiratory or prematurity related complication) and the duration of hospitalization were assessed. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Many used to arrive with patent intestinal parasitic infections. METHODS: We analysed the prevalence of helminth infections in a dataset of 29,286 records of subjects referred for stool examination at the Hamad Medical Corporation over the course of a decade (2005 to 2014, inclusive). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…There was no difference in patency (76 vs. 79 % fully patent), prevalence of PTS (52 vs. 55 %), or quality of life between groups after long-term follow-up (median 65 months, range: 15–141). …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Dentin fluid flow was measured before and after treatment of dentin with patent dentinal tubules using 1 or 3 applications of the dicalcium and tetracalcium phosphate containing agent Teethmate(TM) (TM) and comparing the results with two sodium fluoride varnishes Vella(TM) (VLA) and Vanish(TM) (VAN), after storage in artificial saliva for 24 h, 48 h and 7 days. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: In the early cases, a kidney was placed intraperitoneally at the right iliac fossa with a venous anastomosis to the patent segment of the suprarenal IVC. After 2008, however, 6 adult-sized kidneys were subsequently placed in the left orthotopic position. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…B-lines can be evaluated anywhere (including extreme environmental conditions with pocket size instruments to detect high-altitude pulmonary oedema), anytime (during dialysis to titrate intervention), by anyone (even a novice sonographer after 1 h training), and on anybody (since the chest acoustic window usually remains patent when echocardiography is not feasible). Cardiologists can achieve much diagnostic gain with little investment of technology, training, and time. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Previous studies clearly indicated that serum levels of interleukin (IL)-13 and total IgE (tIgE) might be potentially useful in the evaluation of patents with AD. AIM: To evaluate whether serum levels of sCD25 and sCD30 are suitable biomarkers of AD. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Finally, in 1990, Starzl et al. reported successful use of tacrolimus in patents undergoing liver transplantation and who had rejection despite receiving conventional immunosuppressive treatment. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Although many of these drug derivatives were published in the medical literature, others were merely patented without further characterization. AB‐FUBINACA is an example of one of the new indazole‐carboxamide synthetic cannabinoids introduced in the past year. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…Antiestrogen treatment exhibited unforeseeable effectiveness even on targeted ER-positive tumors. Recent patents propose the detection of ESR1-gene amplification or restoration of ER-alpha expression for prediction of effective antiestrogen treatment, suggesting a crucial inhibitory role of estrogen-signaling against tumor-growth. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…BACKGROUND: There are no uniform workup and follow-up (FU) protocols for patients presenting with cryptogenic embolism (CE) who undergo percutaneous closure of a patent foramen ovale (PFO). METHODS: We prospectively performed a systematic cardiac and neurological FU protocol in all patients who underwent percutaneous PFO closure in order to assess the incidence of subsequent cardiac and neurological adverse events. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso

“…RESULTS: Between July 2012 and June 2016, 21 patients underwent PPVI: 8 with 2D guidance, 6 patients with 3DRA and most recently 7 patients with VN assistance. Patents in the VN group received significantly less absolute and weight indexed contrast when compared with those with 2DA or 3DRA guided PPVI. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso